Recent Updates
Recently added Catalysts
ANIK Positive Sentiment Score: 65/100

Anika to Participate in the Sidoti Small Cap Virtual Investor Conference

Key Takeaway: Anika Therapeutics, Inc. announced its participation in the Sidoti Small Cap Virtual Investor Conference scheduled for March 22, 2023. The management will lead a virtual presentation and Q&A session beginning at 9:15 AM ET. This engagement is part of Anika's commitment to provide insights into their advancements in orthopedic care and their focus on minimally invasive solutions for joint preservation.

Market Sentiment Analysis

POSITIVE FACTORS

  • Anika Therapeutics is actively engaging with investors at the Sidoti Conference.
  • The company highlights its advancements in early intervention orthopedic care.
  • Management will host a presentation with the opportunity for Q&A.

Full Press Release Details

BEDFORD, Mass., March 15, 2023 (GLOBE NEWSWIRE) -- Anika Therapeutics, Inc. (NASDAQ: ANIK), a global joint preservation company in early intervention orthopedics, today announced that management will participate in the Sidoti Small Cap Virtual Investor Conference on Wednesday, March 22, 2023. Anika will host a virtual presentation with Q&A starting at 9:15am ET.
Webcast of the presentation and Q&A will be available in the Investor Relations section of Anika’s website, www.anika.com. An archive of the presentation will also be available on the website.
Anika Therapeutics, Inc. (NASDAQ: ANIK), is a global joint preservation company that creates and delivers meaningful advancements in early intervention orthopedic care. Leveraging our core expertise in hyaluronic acid and implant solutions, we partner with clinicians to provide minimally invasive products that restore active living for people around the world. Our focus is on high opportunity spaces within orthopedics, including osteoarthritis pain management, regenerative solutions, sports medicine soft tissue repair and bone preserving joint technologies, and our products are efficiently delivered in key sites of care, including ambulatory surgery centers. Anika’s global operations are headquartered outside of Boston, Massachusetts. For more information about Anika, please visit www.anika.com.
ANIKA, ANIKA THERAPEUTICS and the Anika logo are registered trademarks of Anika Therapeutics, Inc.
For Investor Inquiries:
Anika Therapeutics, Inc.
Mark Namaroff, 781-457-9287
Vice President, Investor Relations, ESG and Corporate Communications

Frequently Asked Questions

When will Anika Therapeutics present at the investor conference?

Anika Therapeutics will present on March 22, 2023, at 9:15 am ET.

Where can I watch Anika's virtual presentation?

The virtual presentation can be viewed on Anika's Investor Relations website.

What is the focus of Anika Therapeutics?

Anika focuses on advancements in early intervention orthopedic care.

What type of products does Anika Therapeutics offer?

Anika offers minimally invasive products for pain management and joint technologies.

Where is Anika Therapeutics headquartered?

Anika Therapeutics is headquartered near Boston, Massachusetts.

Last updated: Mar 15, 2023